Oncocross Co., Ltd. (382150.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.6x

Market Cap

KRW 41.50B

MomentumView details →

1D Return

−2.68%

YTD Return

−63.94%

RSI (14)

47.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.6x

Market Cap

KRW 41.50B

RSI (14)

47.4

MomentumView details →

1D Return

−2.68%

YTD Return

−63.94%

ProfitabilityView details →

Gross Margin

−311.25%

Net Margin

−1653.24%

EBITDA Margin

−2644.19%

ROE (TTM)

−48.21%

ROA (TTM)

−20.23%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

−61.91%

EPS YoY

+18.03%

FCF YoY

−25.96%

Revenue CAGR 3Y

+35.10%

EPS CAGR 3Y

−20.59%

EBITDA YoY

−94.18%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

1.44x

Quick Ratio

1.44x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

395.50M

Net Income (TTM)

−6.54B

Op. CF (TTM)

−7.16B

Latest newsMore news →

No recent news for 382150.KQ.

Similar companies

IMBdx461030.KQ 3SBio Inc.01530.HK 三生国健688336.SH Revolution Medicines, Inc.RVMD RemeGen Co., Ltd.09995.HK Shanghai Henlius Biotech, Inc.02696.HK Find similar companies →

Latest newsMore news →

No recent news for 382150.KQ.